Evidence map›Paper›PMID 20600227›Full record

ArticleToxicon : official journal of the International Society on Toxinology2010

Inhibition of the activation pathway of the T-type calcium channel Ca(V)3.1 by ProTxII.

Gabrielle B Edgerton, Kenneth M Blumenthal, Dorothy A Hanck

Abstract read
In one paragraph

Article in Toxicon : official journal of the International Society on Toxinology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Unlocking the gating mechanism of Kv2.1 using guangxitoxin.The Journal of general physiology · 2019
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Gabrielle B EdgertonCommittee on Neurobiology, University of Chicago, 5841 S. Maryland Avenue, MC6094, Chicago, IL 60637, USA.
Kenneth M Blumenthal
Dorothy A Hanck
University of Chicago · USUniversity at Buffalo, State University of New York · US

Funding

TRAINING IN NEURAL SYSTEMST32GM007839 · NIGMS · UNIVERSITY OF CHICAGO · PI MASON, PEGGY · 1985 to 2012
$4.2M
CARDIAC CHANNELS--TARGETS OF DRUGS THAT AFFECT KINETICSR01HL065680 · NHLBI · UNIVERSITY OF CHICAGO · PI HANCK, DOROTHY A. · 2000 to 2010
$2.6M
Activation in voltage-gated Na channels modified by the tarantula toxin ProTxllF31NS061535 · NINDS · UNIVERSITY OF CHICAGO · PI EDGERTON, GABRIELLE BLOOM · 2008 to 2010
$73k
NHLBI NIH HHS R01 HL065680NHLBI NIH HHS R01-HL65680NIGMS NIH HHS T32 GM007839NIGMS NIH HHS T32GM7839NINDS NIH HHS F31 NS061535NINDS NIH HHS F31-NS061535
6 · The paper itself

Abstract

Toxins have been used extensively to probe the gating mechanisms of voltage-gated ion channels. Relatively few such tools are available to study the low-voltage activated T-type Ca channels, which underlie thalamic neuron firing and affect sleep, resistance to seizures, and weight gain. Here we show that ProTxII, a peptide toxin recently isolated from the venom of the tarantula spider Thrixopelma pruriens, dose-dependently inhibited Ca(V)3.1 causing a decrease in current (81.6% +/- 3.1% at -30 mV in 5 microM toxin) and a positive shift in the voltage range of activation (+34.5 mV +/- 4.4 mV). Toxin-modified currents were slower to activate and faster to deactivate and they displayed a longer lag in the onset of current, i.e. the Cole-Moore shift, consistent with the inhibition of gating transitions along the activation pathway, particularly the final opening transition. Single-channel current amplitude and total gating charge were unaffected by toxin, ruling out a change in ion flux or channel dropout as mechanisms for the decrease in macroscopic conductance. A positive shift in the voltage range of gating charge movement (+30.6 mV +/- 2.6 mV shift in the voltage of half maximal charge movement in the presence of 5 microM toxin) confirmed that ProTxII-induced gating perturbations in this channel occur at the level of the voltage sensors, and kinetic modeling based on these findings suggested that reductions in current magnitude could be largely accounted for by kinetic perturbations of activation.

Indexed as

Calcium Channel BlockersCalcium Channels, T-TypeCell LineElectric ConductivityHumansPatch-Clamp TechniquesSpider VenomsCACNA1G protein, humanCalcium Channel BlockersCalcium Channels, T-TypeProTx-II peptideSpider Venoms

Identifiers

PMID20600227
PMCPMC2909376
OpenAlexW1966689508

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.